Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status

被引:36
作者
Kim, SZ
Chow, KU
Kukoc-Zivojnov, N
Boehrer, S
Brieger, A
Steimle-Grauer, SA
Harder, L
Hoelzer, D
Mitrou, PS
Weidmann, E
机构
[1] Univ Hosp Frankfurt, Dept Internal Med 3, Frankfurt, Germany
[2] Univ Hosp Frankfurt, Dept Pathol, Frankfurt, Germany
[3] Univ Hosp Kiel, Inst Human Genet, Kiel, Germany
关键词
ZAP-70; B-CLL; Ig V-H; CD38;
D O I
10.1080/10428190410001714016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mutational status of immunoglobutin variable region genes (Ig V-H) is a well established prognostic parameter in chronic lymphocytic leukemia (CLL). Recently, a subset of genes with a characteristic expression profile correlating with the mutational status of B-CLLs has been identified. One of the overexpressed genes in the prognostically unfavorable group of CLL patients with unmutated Ig V-H genes encodes for the protein tyrosine kinase ZAP-70, which is physiologically involved in T-cell signaling. Since ZAP-70 has been described to be prognostically relevant in CLL, we analyzed the possible relationship of its expression to the mutational status Of Ig V-H genes as well as to other prognostic factors in CLL and indolent lymphomas. The mutational status Of Ig V-H genes was analyzed by seminested PCR, direct sequencing and comparison with the sequences of the EMBL databases in 60 samples of patients with B-CLL and 18 samples of patients with indolent B-cell malignancies. ZAP-70 protein expression was assessed in all samples by immunoblotting and for semiquantitative analysis the ratio of ZAP-70 to tubulin expression was calculated. ZAP-70 protein was found to be expressed in all investigated B-cell malignancies. Expression levels varied within a wide range in each entity. The highest mean level of ZAP-70 expression was observed in unmutated B-CLLs, however, with broad expression variability. High levels of ZAP-70 expression correlated with higher stage Binet B or C and with unmutated Ig V-H genes. Overall survival rates estimated by Kaplan-Meier curves did not differ among patients with high or low ZAP-70 expression. We conclude that ZAP-70 is associated with the mutational status Of Ig V-H genes, but this expression pattern is not present in all individual cases. Furthermore, high levels of ZAP-70 correlated with Binet stages B or C indicating an involvement of ZAP-70 in mechanisms promoting growth of B-CLL cells.
引用
收藏
页码:2037 / 2045
页数:9
相关论文
共 29 条
[1]   DEFECTIVE T-CELL RECEPTOR SIGNALING AND CD8(+) THYMIC SELECTION IN HUMANS LACKING ZAP-70 KINASE [J].
ARPAIA, E ;
SHAHAR, M ;
DADI, H ;
COHEN, A ;
ROIFMAN, CM .
CELL, 1994, 76 (05) :947-958
[2]   Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease, represent clonal populations of germinal center-derived tumor B cells [J].
Braeuninger, A ;
Kuppers, R ;
Strickler, JG ;
Wacker, HH ;
Rajewsky, K ;
Hansmann, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9337-9342
[3]   Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells [J].
Bräuninger, A ;
Küppers, R ;
Spieker, T ;
Siebert, R ;
Strickler, JG ;
Schlegelberger, B ;
Rajewsky, K ;
Hansmann, ML .
BLOOD, 1999, 93 (08) :2679-2687
[4]  
CHAN AC, 1994, J IMMUNOL, V152, P4758
[5]   Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia [J].
Chen, LG ;
Widhopf, G ;
Huynh, L ;
Rassenti, L ;
Rai, KR ;
Weiss, A ;
Kipps, TJ .
BLOOD, 2002, 100 (13) :4609-4614
[6]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[7]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[8]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847
[9]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[10]   Immunoglobulin V genes and CD38 expression in CLL [J].
Hamblin, BJ ;
Orchard, JA ;
Gardiner, A ;
Oscier, DG ;
Davis, Z ;
Stevenson, FK .
BLOOD, 2000, 95 (07) :2455-2456